Type 2 diabetes in neuroendocrine tumors: Are biguanides and statins part of the solution?

RAUL MIGUEL LUQUE HUERTASJUSTO PASTOR CASTAÑO FUENTESMANUEL DAVID GAHETE ORTIZ2026-01-292026-01-29201910.1210/jc.2018-014552-s2.0-85065971678https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/30439BiochemistryBiochemistry (medical)Clinical BiochemistryEndocrinologyEndocrinology, Diabetes and MetabolismBiochemistryBiochemistry (medical)Clinical BiochemistryEndocrinologyEndocrinology, Diabetes and MetabolismType 2 diabetes in neuroendocrine tumors: Are biguanides and statins part of the solution?research article